Iftekhar D. Kalsekar, Ph.D. - Publications

Affiliations: 
2004 West Virginia University, Morgantown, WV, United States 
Area:
Pharmacy, Public Health

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Angelo RN, Rahman M, Khanna R, Yeh RW, Goldstein L, Yadalam S, Kalsekar I, Tung P, Zimetbaum PJ. Limited Duration of Antiarrhythmic Drug Use For Newly Diagnosed Atrial Fibrillation in a Nationwide Population Under Age 65. Journal of Cardiovascular Electrophysiology. PMID 33760297 DOI: 10.1111/jce.15012  0.459
2020 Mehta V, Boo LM, Ghaly N, Kalsekar I, Zhang S, Yadalam S, Khanna R, Rahman M. Real-world characteristics and readmissions among patients undergoing ablation for ventricular tachycardia: a retrospective database analysis of commercially insured patients in the USA. Open Heart. 7. PMID 32998979 DOI: 10.1136/openhrt-2020-001247  0.478
2020 Costea A, Goldstein L, Maccioni S, Kalsekar I, Khanna R. Real-world outcomes comparison among adults with atrial fibrillation undergoing catheter ablation with a contact force porous tip catheter versus a second-generation cryoballoon catheter: a retrospective analysis of multihospital US database. Bmj Open. 10: e035499. PMID 32759243 DOI: 10.1136/bmjopen-2019-035499  0.471
2020 Friedman DJ, Pokorney SD, Ghanem A, Marcello S, Kalsekar I, Yadalam S, Akar JG, Freeman JV, Goldstein L, Khanna R, Piccini JP. Predictors of Cardiac Perforation With Catheter Ablation of Atrial Fibrillation. Jacc. Clinical Electrophysiology. 6: 636-645. PMID 32553212 DOI: 10.1016/J.Jacep.2020.01.011  0.439
2020 D'Angelo RN, Khanna R, Yeh RW, Goldstein L, Kalsekar I, Marcello S, Tung P, Zimetbaum PJ. Trends and predictors of early ablation for Atrial Fibrillation in a Nationwide population under age 65: a retrospective observational study. Bmc Cardiovascular Disorders. 20: 161. PMID 32252637 DOI: 10.1186/s12872-020-01446-9  0.459
2020 Field ME, Goldstein L, Yu Lee SH, Kalsekar I, Coplan P, Wong C, Khanna R, Gold MR, Reynolds MR, Winterfield JR. Intracardiac echocardiography use and outcomes after catheter ablation of ventricular tachycardia. Journal of Comparative Effectiveness Research. PMID 32134325 DOI: 10.2217/cer-2019-0156  0.453
2019 Field ME, Gold MR, Reynolds MR, Goldstein L, Lee SHY, Kalsekar I, Coplan P, Wong C, Khanna R, Winterfield JR. Real-World Outcomes of Ventricular Tachycardia Catheter Ablation with versus without Intracardiac Echocardiography. Journal of Cardiovascular Electrophysiology. PMID 31868258 DOI: 10.1111/jce.14324  0.455
2019 Rai AT, Crivera C, Kottenmeier E, Kalsekar I, Kumari R, Patino N, Chekani F, Khanna R. Outcomes associated with endovascular treatment among patients with acute ischemic stroke in the USA. Journal of Neurointerventional Surgery. PMID 31649206 DOI: 10.1136/neurintsurg-2019-015378  0.45
2019 Rai AT, Crivera C, Kalsekar I, Kumari R, Patino N, Chekani F, Khanna R. Endovascular Stroke Therapy Trends From 2011 to 2017 Show Significant Improvement in Clinical and Economic Outcomes. Stroke. STROKEAHA119025112. PMID 31104618 DOI: 10.1161/STROKEAHA.119.025112  0.449
2018 Pollak SJ, Goldstein L, Daskiran M, Kalsekar I, Khanna R. Economic impact of atrial fibrillation ablation with radiofrequency contact force catheter versus cryoballoon catheter. Journal of Comparative Effectiveness Research. PMID 30572711 DOI: 10.2217/cer-2018-0112  0.457
2018 Jarman JWE, Hussain W, Wong T, Markides V, March J, Goldstein L, Liao R, Kalsekar I, Chitnis A, Khanna R. Resource use and clinical outcomes in patients with atrial fibrillation with ablation versus antiarrhythmic drug treatment. Bmc Cardiovascular Disorders. 18: 211. PMID 30404603 DOI: 10.1186/s12872-018-0946-6  0.486
2018 Chinitz L, Goldstein LJ, Barnow A, Maccioni S, Daskiran M, Kalsekar I, Khanna R. Comparison of real-world clinical and economic outcomes between the ThermoCool SF and ThermoCool catheters in patients undergoing radiofrequency catheter ablation for atrial fibrillation. Clinicoeconomics and Outcomes Research : Ceor. 10: 587-599. PMID 30323636 DOI: 10.2147/CEOR.S180125  0.479
2018 Barnow A, Canfield T, Liao R, Yadalam S, Kalsekar I, Khanna R. Breast Reconstruction Among Commercially Insured Women With Breast Cancer in the United States. Annals of Plastic Surgery. PMID 29781849 DOI: 10.1097/SAP.0000000000001454  0.37
2018 Barnow A, Goldstein L, Kalsekar I, Liao R, Khanna R. Use of the THERMOCOOL SMARTTOUCH Catheter for ablation of atrial fibrillation: the relationship between hospital procedure volume, readmissions and economic outcomes. Journal of Medical Economics. 1-16. PMID 29297705 DOI: 10.1080/13696998.2018.1423566  0.461
2010 Kalsekar I, Record S, Nesnidal K, Hancock B. National estimates of enrollment in disease management programs in the United States: an analysis of the National Ambulatory Medical Care Survey data. Population Health Management. 13: 183-8. PMID 20735245 DOI: 10.1089/Pop.2009.0056  0.303
2008 Dino G, Horn K, Abdulkadri A, Kalsekar I, Branstetter S. Cost-effectiveness analysis of the not on tobacco program for adolescent smoking cessation Prevention Science. 9: 38-46. PMID 18286372 DOI: 10.1007/S11121-008-0082-0  0.315
2007 Kalsekar I, Sheehan C, Peak A. Utilization patterns and medication adherence in patients with type 2 diabetes: Variations based on type of pharmacy (chain vs independent) Research in Social and Administrative Pharmacy. 3: 378-391. PMID 18082874 DOI: 10.1016/J.Sapharm.2006.11.002  0.341
2007 Hassan M, Madhavan SS, Kalsekar ID, Makela EH, Rajagopalan K, Islam S, Kavookjian J, Miller LA. Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder. The Annals of Pharmacotherapy. 41: 1812-8. PMID 17925501 DOI: 10.1345/Aph.1K205  0.631
2007 Mody R, Kalsekar I, Kavookjian J, Iyer S, Rajagopalan R, Pawar V. Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes. Journal of Diabetes and Its Complications. 21: 75-83. PMID 17331855 DOI: 10.1016/J.Jdiacomp.2006.02.005  0.305
2007 Hassan M, Madhavan S, Kalsekar I, Rajagopalan K, Islam S, Kavookjian J, Miller L, Makela E. PMH33 PROFILING UTILIZATION PATTERNS OF ANTIPSYCHOTICS AMONG PATIENTS WITH BIPOLAR DISORDER:A CLAIMS DATA ANALYSIS Value in Health. 10: A81. DOI: 10.1016/S1098-3015(10)68784-0  0.617
2006 Kalsekar ID, Madhavan SS, Amonkar MM, Douglas SM, Makela E, Elswick BL, Scott V. Impact of depression on utilization patterns of oral hypoglycemic agents in patients newly diagnosed with type 2 diabetes mellitus: a retrospective cohort analysis. Clinical Therapeutics. 28: 306-18. PMID 16678652 DOI: 10.1016/J.Clinthera.2006.02.005  0.498
2006 Kalsekar ID, Madhavan SM, Amonkar MM, Scott V, Douglas SM, Makela E. The effect of depression on health care utilization and costs in patients with type 2 diabetes. Managed Care Interface. 19: 39-46. PMID 16583789  0.464
2006 Kalsekar ID, Madhavan SS, Amonkar MM, Makela EH, Scott VG, Douglas SM, Elswick BL. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents. The Annals of Pharmacotherapy. 40: 605-11. PMID 16551768 DOI: 10.1345/Aph.1G606  0.514
2006 Kalsekar I, Iyer S, Mody R, Rajagopalan R, Kavookjian J. Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population. Journal of Managed Care Pharmacy : Jmcp. 12: 121-9. PMID 16515370 DOI: 10.18553/Jmcp.2006.12.2.121  0.32
2006 Hassan M, Madhavan S, Rajagopalan K, Kalsekar I, Islam S, Makela E, Kavookjian J, Miller L. PMH37 COMPARING ADHERENCE AND PERSISTENCE WITH ANTIPSYCHOTIC THERAPY AMONG PATIENTS WITH BIPOLAR DISORDER Value in Health. 9: A75-A76. DOI: 10.1016/S1098-3015(10)64538-X  0.634
2006 Hassan M, Madhavan S, Rajagopalan K, Kalsekar I, Islam S, Makela E, Kavookjian J, Miller L. PMH32 ANTIPSYCHOTIC THERAPY IN PATIENTS WITH BIPOLAR DISORDER: EFFECTS ON TOTAL AND MENTAL HEALTH CARE COSTS Value in Health. 9: A74. DOI: 10.1016/S1098-3015(10)64533-0  0.617
2006 Sheehan C, Kalsekar I, Peak A. Pdb29 Impact Of Type Of Pharmacy (Chain Versus Independent) On Medication Adherence In Patients With Type 2 Diabetes: A Retrospective Database Analysis Value in Health. 9. DOI: 10.1016/S1098-3015(10)64427-0  0.302
2005 Kalsekar I, Madhavan S, Amonkar M, Douglas S, Makela E, Scott V. Pdb25 Depression In Patients With Type-2 Diabetes: Impact On Utilization Patterns And Adherence To Oral Hypoglycemic Agents Value in Health. 8: 359-360. DOI: 10.1016/S1098-3015(10)62958-0  0.316
2005 Mody R, Kalsekar I, Kavookjian J, Iyer S, Rajagopalan R, Pawar V. PDB24 ECONOMIC IMPACT OF CARDIOVASCULAR CO-MORBIDITY IN PATIENTS WITH TYPE-2 DIABETES Value in Health. 8: 359. DOI: 10.1016/S1098-3015(10)62957-9  0.307
2005 Kavookjian J, Mody R, Kalsekar I, Iyer S, Rajagopalan R, Pawar V. PDB1 PREVALENCE OF CO-MORBID CONDITIONS AND CONCOMITANT MEDICATION USE AMONG TYPE-2 DIABETES PATIENTS IN A STATE MEDICAID POPULATION Value in Health. 8: 352. DOI: 10.1016/S1098-3015(10)62934-8  0.311
2004 Dino G, Kamal K, Horn K, Kalsekar I, Fernandes A. Stage of change and smoking cessation outcomes among adolescents. Addictive Behaviors. 29: 935-40. PMID 15219338 DOI: 10.1016/J.Addbeh.2004.01.004  0.644
2004 Horn KA, Dino GA, Kalsekar ID, Fernandes AW. Appalachian teen smokers: not on tobacco 15 months later. American Journal of Public Health. 94: 181-4. PMID 14759924 DOI: 10.2105/Ajph.94.2.181  0.572
2003 Horn K, Fernandes A, Dino G, Massey CJ, Kalsekar I. Adolescent nicotine dependence and smoking cessation outcomes. Addictive Behaviors. 28: 769-76. PMID 12726789 DOI: 10.1016/S0306-4603(02)00229-0  0.571
Show low-probability matches.